Delphi panels and the case for consensus
In the hierarchy of evidence, randomized controlled trials are the gold standard. While seeking expert opinion will never compare in terms of scientific rigor, it can be a valuable option in cases of limited, insufficient, or conflicting information. This is, of...
Join our ISPOR short course
Join Dr Mark Larkin, Dr Catherine Bottomley, and Dr Casey Quinn for the virtual ISPOR short course on Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology. The course is designed to provide a good understanding of how to plan and undertake...
Should I stay or should I go? Patient engagement and retention in real-world studies
In April 2022, Industry Standard Research conducted a survey on behalf of PPD (the clinical research business of Thermo Fisher Scientific) with 152 leaders of biotech and pharmaceutical organizations worldwide to gather their insights on industry trends. Not only did...
Micro-moments: how and why to capture them with RWD
This blog is based on a webinar hosted by Vitaccess. For access to this webinar, and all webinars that we have hosted, please visit our dedicated webinars page. What is a “micro-moment”? During a clinician visit, you are much more likely to have accurate recall of a...
